vimarsana.com

Page 10 - எங்களுக்கு தேசிய புற்றுநோய் நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Sesen Bio Announces Commercial Launch Readiness Progress as the Company Approaches the Potential Approval and Launch of Vicineum™

Published: May 04, 2021   Selected Syneos Health Company remains on track for potential approval in the US in August 2021   Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today announced the expansion of its leadership team with the appointment of experienced commercial industry leader, Lisa LaMond, as Vice President, Sales and Corporate Systems. The Company also announced its engagement of leading contract sales organization (CSO), Syneos Health, for field sales support and execution in the US for Vicineum. Lisa LaMond brings invaluable experience in commercial pharmaceuticals to her role as Vice President, Sales and Corporate Systems. Prior to joining Sesen Bio, Ms. LaMond spent her career at Merck & Co. Inc. where she developed a diverse skillset across key commercial functions, as well as a deep understanding of the evolving healthcare environment and customer landscap

How many steps per day are necessary to live a long life

4 May in 16:35 Daily walks can become the key to longevity,  scientists from the US National Cancer Institute and the Institute of Aging report. The study lasted three years. Participants in the experiment over 40 years old wore special accelerometers. Thus, the data from the sensors allowed scientists to calculate the correlation between mortality and the number of steps, the Journal of the American Medical Association informs. ”8,000 steps reduce the risk of death from all causes in 51% of people, 12,000 steps reduce the risk by 65%, the American researchers report. 3725 views

Too few young men have received HPV vaccine, experts say

Too few young men have received HPV vaccine, experts say By The HPV vaccine isn t reaching enough young American men, researchers report. The vaccine protects against reproductive warts as well as cancers caused by human papillomavirus, or HPV, the most common sexually transmitted infection in the United States. Advertisement Many young women get the HPV vaccine to help protect them against cervical cancer, but numbers are much lower among young men, the Michigan Medicine-University of Michigan researchers found. The U.S. Food and Drug Administration approved the vaccine for women in 2006 and expanded it to men in 2009. When the HPV vaccine was first introduced, the main goal was to prevent cervical cancer.

Chernobyl s liquidators didn t pass on radiation damage to their children -- Science & Technology -- Sott net

© Shutterstock Chernobyl Nuclear Power Plant Radiation exposure from the 1986 Chernobyl disaster the world s deadliest nuclear accident raised the risk of certain mutations linked to thyroid cancer, but it didn t cause new mutations in DNA that parents who cleaned up after the nuclear accident passed along to their children, two new studies find. The new research is a step forward in understanding the mechanisms that drive human thyroid cancer, said Stephen Chanock, the director of the division of cancer epidemiology and genetics at the U.S. National Cancer Institute (NCI) and the senior author on both research papers. It s also reassuring for those exposed to radiation in events such as the 2011 Fukushima nuclear power plant disaster and who plan to start families, Chanock told Live Science.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.